154 related articles for article (PubMed ID: 7591140)
21. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis.
Tsuji H; Harada A; Mukaida N; Nakanuma Y; Bluethmann H; Kaneko S; Yamakawa K; Nakamura SI; Kobayashi KI; Matsushima K
Infect Immun; 1997 May; 65(5):1892-8. PubMed ID: 9125577
[TBL] [Abstract][Full Text] [Related]
23. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
24. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
26. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.
Matsui K; Yoshimoto T; Tsutsui H; Hyodo Y; Hayashi N; Hiroishi K; Kawada N; Okamura H; Nakanishi K; Higashino K
J Immunol; 1997 Jul; 159(1):97-106. PubMed ID: 9200444
[TBL] [Abstract][Full Text] [Related]
27. JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice.
Kakutani M; Takeuchi K; Waga I; Iwamura H; Wakitani K
Inflamm Res; 1999 Aug; 48(8):461-8. PubMed ID: 10493164
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of NO in both unchallenged and LPS-challenged C. parvum-primed mice are attributable to the activity of a cytokine-inducible isoform of iNOS.
Smith SR; Manfra D; Davies L; Terminelli C; Denhardt G; Donkin J
J Leukoc Biol; 1997 Jan; 61(1):24-32. PubMed ID: 9000533
[TBL] [Abstract][Full Text] [Related]
29. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice.
Fujioka N; Mukaida N; Harada A; Akiyama M; Kasahara T; Kuno K; Ooi A; Mai M; Matsushima K
J Leukoc Biol; 1995 Jul; 58(1):90-8. PubMed ID: 7616110
[TBL] [Abstract][Full Text] [Related]
30. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.
DeForge LE; Kenney JS; Jones ML; Warren JS; Remick DG
J Immunol; 1992 Apr; 148(7):2133-41. PubMed ID: 1545121
[TBL] [Abstract][Full Text] [Related]
31. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury.
Arai T; Hiromatsu K; Kobayashi N; Takano M; Ishida H; Nimura Y; Yoshikai Y
J Immunol; 1995 Dec; 155(12):5743-9. PubMed ID: 7499862
[TBL] [Abstract][Full Text] [Related]
32. Experimental liver injury induced by Propionibacterium acnes and lipopolysaccharide in macrophage colony stimulating factor-deficient osteopetrotic (op/op) mice.
Nishioji K; Okanoue T; Mori T; Sakamoto S; Itoh Y
Dig Dis Sci; 1999 Oct; 44(10):1975-84. PubMed ID: 10548345
[TBL] [Abstract][Full Text] [Related]
33. Hepatoprotective effect of SY-640, a novel acetamide derivative, on Propionibacterium acnes and lipopolysaccharide-induced liver injury in mice.
Tanaka Y; Takahashi A; Kobayashi K; Arai I; Higuchi S; Otomo S; Wei HL; Liu GT
Arch Int Pharmacodyn Ther; 1995; 329(2):319-30. PubMed ID: 8540770
[TBL] [Abstract][Full Text] [Related]
34. Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis.
Taguchi I; Oka K; Kitamura K; Sugiura M; Oku A; Matsumoto M
Inflamm Res; 1999 Jul; 48(7):380-5. PubMed ID: 10450787
[TBL] [Abstract][Full Text] [Related]
35. The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.
Koyanagi T; Nakamuta M; Enjoji M; Iwamoto H; Motomura K; Sakai H; Nawata H
Int J Mol Med; 2001 Mar; 7(3):321-7. PubMed ID: 11179515
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-12 regulates natural killer cell-dependent Propionibacterium acnes-primed, lipopolysaccharide-induced liver injury.
Margenthaler JA; Ku G; Flye MW
Hepatol Res; 2008; 38(2):183-93. PubMed ID: 18197879
[TBL] [Abstract][Full Text] [Related]
37. Induction of tumor necrosis factor by macrophage colony-stimulating factor in vivo.
Zhu D; Zhang H; Gao N; Tao X; Han K; Shing Y
J Biol Response Mod; 1990 Jun; 9(3):339-42. PubMed ID: 2199615
[TBL] [Abstract][Full Text] [Related]
38. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor.
Yoshimoto T; Nakanishi K; Hirose S; Hiroishi K; Okamura H; Takemoto Y; Kanamaru A; Hada T; Tamura T; Kakishita E
J Immunol; 1992 Jun; 148(11):3596-603. PubMed ID: 1588048
[TBL] [Abstract][Full Text] [Related]
39. Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice.
Liu P; Ohnishi H; Moriwaki H; Muto Y
Gastroenterol Jpn; 1990 Jun; 25(3):339-42. PubMed ID: 2358165
[TBL] [Abstract][Full Text] [Related]
40. Induction of murine gamma interferon production by lipopolysaccharide and interleukin-2 in Propionibacterium acnes-induced peritoneal exudate cells.
Okamura H; Wada M; Nagata K; Tamura T; Shoji K
Infect Immun; 1987 Feb; 55(2):335-41. PubMed ID: 3100448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
